Incyte reported $1.57 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 1.58 1.07 Nov/04 2025
FY2025Q2 Jun/2025 1.57 1.40 -1.82 Jul/29 2025
FY2025Q1 Mar/2025 1.16 1.01 0.64 Apr/29 2025
FY2024Q4 Dec/2024 1.43 1.51 1.06 Feb/10 2025
FY2024Q3 Sep/2024 1.07 1.03 0.76 Oct/29 2024
FY2024Q2 Jun/2024 -1.82 0.87 0.99 Jul/30 2024
FY2024Q1 Mar/2024 0.64 0.82 0.37 Apr/30 2024
FY2023Q4 Dec/2023 1.06 1.14 0.62 Feb/13 2024
FY2023Q3 Sep/2023 0.76 0.88 0.60 Oct/31 2023
FY2023Q2 Jun/2023 0.99 0.79 1.01 Aug/01 2023
FY2023Q1 Mar/2023 0.37 0.75 0.55 May/02 2023
FY2022Q4 Dec/2022 0.62 0.57 0.1 Feb/07 2023


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Exelixis USD 0.75 0.13 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
MacroGenics USD -0.57 0.32 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Novartis USD 2.06 0.08 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025